Gene expression profiling is a comprehensive molecular testing technology that quantifies messenger RNA transcripts across thousands of genes simultaneously, providing a global snapshot of cellular function and biological activity. Performed by accredited third-party laboratories in accordance with international standards such as ISO/IEC 17025 and ISO 20395, this analysis supports drug development, disease research, agricultural biotechnology, and precision medicine. This article explains the core technologies, sample requirements, testing items, analytical methods, and practical applications of gene expression profiling services.
Technical Overview
Gene expression profiling, also known as transcriptome analysis, is the systematic measurement of the abundance and activity of gene transcripts within a biological sample at a given time. By quantifying messenger RNA (mRNA) and other RNA species on a genome-wide scale, this technology reveals which genes are active, which pathways are engaged, and how cells or tissues respond to stimuli such as disease, drug treatment, environmental stress, or genetic modification.
Modern gene expression profiling relies primarily on three technology platforms: next-generation sequencing (RNA-seq), high-density oligonucleotide microarrays, and quantitative reverse transcription PCR (qRT-PCR). RNA-seq has become the dominant approach due to its dynamic range, sensitivity, and ability to discover novel transcripts, splice variants, fusion genes, and non-coding RNAs without prior knowledge of the sequence space. Microarrays remain a cost-effective option for well-characterized genomes, while qRT-PCR serves as the gold-standard method for targeted validation of differentially expressed genes.
A complete gene expression profiling workflow encompasses sample receipt and RNA extraction, RNA quality control, library preparation or array hybridization, sequencing or scanning, bioinformatic analysis, and statistical interpretation. Professional testing is typically conducted in laboratories accredited to ISO/IEC 17025 for general testing competence, with nucleic acid quantification performance evaluated according to ISO 20395, and clinical applications performed under ISO 15189 medical laboratory requirements. Pre-analytical handling may follow ISO 20166 specifications to ensure specimen integrity.
Testing Samples
Animal and Human Tissues
Fresh-frozen tissue, tissue preserved in RNA stabilization reagents, and formalin-fixed paraffin-embedded (FFPE) blocks are all acceptable sample types. Fresh-frozen tissue generally yields the highest RNA integrity, while FFPE samples can be analyzed using specialized protocols such as ribosomal RNA depletion and RNA fragmentation-tolerant library preparation.
Blood and Body Fluids
Whole blood, peripheral blood mononuclear cells (PBMCs), bone marrow aspirates, cerebrospinal fluid, and other biofluids can be profiled using RNA stabilization tubes that prevent ex vivo transcriptional changes during transport. Platelet-poor plasma and serum are suitable for circulating non-coding RNA analysis.
Cell Lines and Primary Cells
Cultured cell pellets, sorted cell populations, and single-cell suspensions are ideal inputs for bulk RNA-seq and single-cell RNA-seq. Cells should be washed, pelleted, and snap-frozen or placed directly into lysis buffer to preserve the in vivo expression state.
Plant Tissues
Leaves, roots, seeds, fruits, flowers, and callus tissue from crops, medicinal plants, and model organisms are routinely tested. Plant samples are typically flash-frozen in liquid nitrogen immediately after harvest to inactivate abundant plant RNases and secondary metabolites.
Microbial and Environmental Samples
Bacterial pellets, fungal mycelium, yeast cultures, activated sludge, soil, and water concentrates can be analyzed using microbial RNA-seq protocols with host or ribosomal RNA depletion to enrich for messenger transcripts.
Sample Quality Requirements
- Total RNA amount: generally 100 ng to 1 µg for standard RNA-seq library preparation; low-input protocols accept as little as 10 pg to 10 ng.
- RNA integrity number (RIN): 7.0 or above recommended for standard mRNA-seq; partially degraded samples (RIN 2.5–7) may be processed with rRNA depletion methods.
- Purity: A260/A280 ratio of 1.8–2.1 and A260/A230 ratio above 1.8, indicating minimal protein, phenol, and salt contamination.
- Storage and transport: samples shipped on dry ice at −80 °C conditions or in ambient-temperature RNA stabilization reagents, with full chain-of-custody documentation.
Testing Items
Gene expression profiling services cover a broad portfolio of analytical deliverables, tailored to research, clinical, and industrial objectives:
- Whole transcriptome expression profiling: genome-wide quantification of all protein-coding gene transcripts.
- Differential expression analysis: identification of up-regulated and down-regulated genes between experimental groups (e.g., treated versus control, diseased versus healthy).
- Non-coding RNA profiling: expression analysis of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs).
- Alternative splicing analysis: detection of transcript isoforms and splicing events across conditions.
- Gene fusion detection: identification of expressed fusion transcripts relevant to oncology and genetic research.
- Single-cell expression profiling: cell-type-specific gene expression mapping and cell cluster characterization at single-cell resolution.
- Pathway and functional enrichment analysis: Gene Ontology (GO) and KEGG pathway enrichment of significant gene sets.
- Co-expression network and biomarker screening: weighted gene co-expression network analysis (WGCNA) and machine-learning-based candidate biomarker selection.
- Targeted expression validation: qRT-PCR and digital PCR confirmation of selected genes using independent biological replicates.
Testing Methods
RNA Sequencing (RNA-seq)
Total RNA or purified mRNA is converted into cDNA libraries using poly(A) selection for eukaryotic samples or ribosomal RNA depletion for degraded, prokaryotic, or non-polyadenylated samples. Libraries are sequenced on high-throughput short-read platforms, typically generating 20–50 million paired-end reads per sample. Reads are quality-filtered, aligned to a reference genome, and quantified as FPKM, TPM, or raw counts, followed by differential expression statistics using negative binomial models.
Microarray Hybridization
Labeled cDNA or cRNA is hybridized to whole-transcriptome oligonucleotide arrays. Fluorescence intensities are scanned and normalized to yield absolute expression measurements. Microarrays offer standardized probe design, lower per-sample cost for large cohorts, and mature analysis pipelines for well-annotated genomes.
Quantitative RT-PCR (qRT-PCR)
Reverse transcription followed by real-time fluorescent PCR quantifies selected transcripts with high sensitivity and a wide dynamic range. Relative quantification uses the comparative cycle threshold method normalized to validated reference genes. Assays are designed and reported in accordance with MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) guidelines to ensure reproducibility.
Digital PCR
Droplet or chamber-based digital PCR partitions reactions into thousands of individual compartments, enabling absolute quantification of transcript copy number without standard curves. It is particularly valuable for low-abundance transcripts and validation of RNA-seq findings.
Single-Cell RNA Sequencing
Individual cells are isolated using droplet-based microfluidic or plate-based capture systems, barcoded, and sequenced to generate expression matrices for thousands to tens of thousands of single cells. This method resolves cellular heterogeneity, rare cell populations, and cell-state transitions within complex tissues.
Bioinformatics and Quality Control
- Raw data quality assessment with base-calling quality metrics and adapter trimming.
- Reference alignment rates, duplication rates, rRNA contamination, and gene body coverage monitored against ISO 20395 performance criteria for nucleic acid quantification.
- Normalization, batch-effect correction, and false discovery rate control in differential expression testing.
- Comprehensive reporting with volcano plots, heatmaps, PCA clustering, and enrichment summaries.
Applications
Gene expression profiling delivers actionable data across diverse scientific and industrial sectors:
- Oncology and precision medicine: molecular subtyping of tumors, prognosis prediction, identification of therapeutic targets, and development of companion diagnostic expression signatures.
- Drug discovery and development: target identification, mechanism-of-action studies, compound efficacy ranking, and toxicogenomic safety screening that reduces late-stage attrition.
- Infectious disease research: host-pathogen interaction studies, immune response characterization, and vaccine evaluation through host transcriptomic signatures.
- Agricultural biotechnology: crop trait improvement, stress-tolerance gene discovery, seed quality evaluation, and safety assessment of genetically modified organisms.
- Food science: authenticity verification of food ingredients, detection of pathogen virulence activity, and shelf-life studies of probiotic cultures.
- Environmental and ecotoxicology studies: biomonitoring of pollutant exposure, soil microbial community activity assessment, and ecological risk evaluation.
- Basic research: developmental biology, cell differentiation trajectories, gene regulatory network construction, and functional genomics validation.
FAQ
How much RNA is required for gene expression profiling?
Standard RNA-seq library preparation typically requires 100 ng to 1 µg of total RNA with a RIN of 7 or higher. Ultralow-input protocols can work with as little as 10 pg of RNA, and degraded FFPE-derived RNA can be accommodated using rRNA depletion strategies after individualized quality assessment.
What is the difference between RNA-seq and microarray testing?
RNA-seq sequences transcripts directly, offering a wider dynamic range, detection of novel transcripts and splice isoforms, and better quantification of low-abundance genes. Microarrays measure hybridization to predefined probes, providing a lower-cost, high-throughput option for well-annotated genomes but cannot detect unknown sequences. Many projects combine RNA-seq discovery with qRT-PCR validation.
Can degraded or FFPE samples be tested?
Yes. FFPE and partially degraded samples with RIN values between roughly 2.5 and 7 can be profiled using ribosomal RNA depletion and short-insert library protocols. Laboratories assess each sample individually and report pre-analytical quality metrics transparently.
Can species without a reference genome be analyzed?
Yes. For non-model organisms, de novo transcriptome assembly can be performed, producing a reference transcript set against which expression is quantified. This approach is widely used for wild plants, minor crops, and non-model animals.
What is the typical turnaround time?
Standard whole-transcriptome RNA-seq projects, from sample QC to bioinformatics reporting, are generally completed within two to six weeks depending on sample number, sequencing depth, and analysis complexity. Targeted qRT-PCR validation projects are typically faster.
How is data quality and reliability ensured?
Accredited third-party laboratories operate under ISO/IEC 17025 quality management systems, apply ISO 20395 criteria for nucleic acid quantification performance, follow MIQE guidelines for qRT-PCR, and include biological replicates, calibrated controls, spike-in standards where appropriate, and comprehensive QC reporting in every project.
